Crossmark

Indication of Omalizumab for Chronic Urticaria Using the ‘Urticaria Control Test’ Instead of ‘Urticaria Activity Score’: Possible Impact for Health Systems

Crossref DOI link: https://doi.org/10.1016/j.ad.2022.10.044

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez, J.

Alvarez, L.

López, J.F.
License Information

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Indication of Omalizumab for Chronic Urticaria Using the ‘Urticaria Control Test’ Instead of ‘Urticaria Activity Score’: Possible Impact for Health Systems

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2022.10.044

Content Type: simple-article

Copyright: © 2023 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below